Showing results (1-10 of 538) with videos related to
Sort By:
Pageof 54
Current Oncology Reports|January 26, 2020
Advances in Therapy for Relapsed or Refractory Hodgkin LymphomaYun Choi, Catherine S DiefenbachCurrent Hematologic Malignancy Reports|March 16, 2020
Polatuzumab Vedotin: a New Target for B Cell MalignanciesYun Choi, Catherine S DiefenbachExpert Review of Hematology|August 22, 2019
An evaluation of brentuximab vedotin as a treatment option for stage III/IV Hodgkin lymphomaYun Choi, Catherine S DiefenbachHematology. American Society of Hematology. Education Program|December 4, 2020
Immunotherapy with drugsYun Choi, Catherine S DiefenbachClinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 15, 2023
On the Precipice of a "Rituximab-Like" Era for T-Cell Lymphomas?Gaurav Varma, Catherine S DiefenbachClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2018
Immunity War: A Novel Therapy for Lymphoma Using T-cell Bispecific AntibodiesAjay Prakash, Catherine S DiefenbachClinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 3, 2024
KLRG1, Another Opportunity for a Breakthrough in MTCLGaurav Varma, Catherine S DiefenbachTherapeutic Advances in Hematology|May 21, 2019
Immune targeting of the microenvironment in classical Hodgkin's lymphoma: insights for the hematologistNicole A Carreau, Catherine S DiefenbachOncology (Williston Park, N.Y.)|October 19, 2016
Checkpoint Inhibition in Hodgkin Lymphoma: Saving the Best for Last?Richard J Lin, Catherine S DiefenbachBlood|August 18, 2017
Role of anthracycline and comprehensive geriatric assessment for elderly patients with diffuse large B-cell lymphomaRichard J Lin, Madhusmita Behera, Catherine S Diefenbach, et al.Pageof 54